These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32569772)

  • 1. Poor Outcome of Intestinal Ischemic Manifestations of COVID-19.
    Norsa L; Bonaffini PA; Indriolo A; Valle C; Sonzogni A; Sironi S
    Gastroenterology; 2020 Oct; 159(4):1595-1597.e1. PubMed ID: 32569772
    [No Abstract]   [Full Text] [Related]  

  • 2. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
    Pooni RS
    Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
    Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
    Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
    [No Abstract]   [Full Text] [Related]  

  • 5. Intra-arterial thrombosis associated with COVID-19.
    Hamilton KV; Hussey KK
    J Vasc Surg; 2020 Aug; 72(2):757-758. PubMed ID: 32425325
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and thrombosis: Beyond a casual association.
    López Castro J
    Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemostasis profile in COVID-19 infection.
    Duarte FB; Machado RPG; Lemes RPG; Duarte IA; Duarte BA; Machado CMG; Duarte JVA; Rocha SGMD; Moura ATG; Holanda RARR
    Rev Assoc Med Bras (1992); 2020 May; 66(5):571-572. PubMed ID: 32638971
    [No Abstract]   [Full Text] [Related]  

  • 11. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19.
    Martinelli N; Montagnana M; Pizzolo F; Friso S; Salvagno GL; Forni GL; Gianesin B; Morandi M; Lunardi C; Lippi G; Polati E; Olivieri O; De Franceschi L
    Thromb Res; 2020 Sep; 193():170-172. PubMed ID: 32707276
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
    Levi M; Thachil J
    Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thromboembolism and COVID-19.
    Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
    Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
    Bilaloglu S; Aphinyanaphongs Y; Jones S; Iturrate E; Hochman J; Berger JS
    JAMA; 2020 Aug; 324(8):799-801. PubMed ID: 32702090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and SIC (!).
    Nevzorov I; Tulamo R; Albäck A; Lassila R
    J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
    [No Abstract]   [Full Text] [Related]  

  • 16. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.
    Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ
    Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008
    [No Abstract]   [Full Text] [Related]  

  • 17. A dermatologic manifestation of COVID-19: Transient livedo reticularis.
    Manalo IF; Smith MK; Cheeley J; Jacobs R
    J Am Acad Dermatol; 2020 Aug; 83(2):700. PubMed ID: 32283229
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 and Stroke in a New York Healthcare System.
    Yaghi S; Ishida K; Torres J; Mac Grory B; Raz E; Humbert K; Henninger N; Trivedi T; Lillemoe K; Alam S; Sanger M; Kim S; Scher E; Dehkharghani S; Wachs M; Tanweer O; Volpicelli F; Bosworth B; Lord A; Frontera J
    Stroke; 2020 Jul; 51(7):2002-2011. PubMed ID: 32432996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related D-dimer elevation and occasional lethality in SARS-CoV-2 infected patients].
    Nagy Z; Vásárhelyi B; Vajda Z
    Orv Hetil; 2020 Oct; 161(41):1739-1743. PubMed ID: 33040043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.